NCT05846503

Brief Summary

Using qualitative data during the formative phase the IHEART-SA research study filled deficiencies in knowledge regarding: 1) what barriers exist to integrating hypertension care within the HIV care setting in South Africa and, 2) how a hypertension care intervention can be adapted to effectively and sustainably function in this care setting. These data have been used to design a context-relevant intervention package for implementation in the next phase of effectiveness-implementation testing, answering the research question: How does an intervention aimed at enhancing hypertension diagnosis and management in people living with HIV improve the delivery of guideline-recommended care in primary healthcare clinics in Gauteng, South Africa, and hypertension control among patients? The study will use an effectiveness-implementation study design. This design allows for the testing of strategies to promote integration of proven interventions in real-world practice (i.e., implementation strategies), while simultaneously assessing clinical effectiveness (i.e., patient level outcomes). For this the study will use a randomized cluster stepped-wedge study design where nine clinics (grouped in clusters of three) will be assigned to a time at which they initiate the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,378

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
26 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

April 12, 2023

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Healthcare worker

    Difference in percentage of patient visits with recorded BP measurement between intervention and control clinics

    24 months

  • Patient

    Difference in mean systolic BP between the intervention and control conditions

    12 months

Secondary Outcomes (8)

  • Healthcare worker implementation

    24 months

  • Healthcare worker adoption

    24 months

  • Healthcare worker maintenance - BP measurement

    12 months

  • Healthcare worker satisfaction

    24 months

  • Healthcare worker costing

    27 months

  • +3 more secondary outcomes

Study Arms (2)

Intervention

OTHER

Cluster of clinics receiving the five investigational interventions

Behavioral: 1. Quality and info management system

Control

NO INTERVENTION

Standard of care

Interventions

1. The intervention package prioritizes information and quality management with a focus on HTN screening, diagnosis, and treatment. From the point-of-care, flow charts placed in the patient file will ensure that vitals are performed in accordance with national guidelines. 2. The care coordinator will present data to clinic staff in multi-disciplinary meetings, providing an opportunity for programmatic feedback and discussion. 3. Patients will be encouraged to complete the vital signs measurements at each clinic visit. They will be provided with their BP readings and given info about what their reading means. They will be issued with pocket sized color coded booklets providing info on the measurement and what to do to control their BP. 4. Task shifting: A care coordinator will be the champion of the intervention package for the clinic. 5. All staff will receive apt training on how to use the patient flow chart, info management system and how to respond to abnormal BP values.

Also known as: 2. Case review meetings, 3. Patient health education and support, 4. Task shifting, 5. HCW education and training
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthcare workers:
  • Adult \>18 years men and women working in clinical roles at the selected clinics
  • Provide informed consent (only those participating in the qualitative components)
  • Patients:
  • Adults \>18 years living with HIV and hypertension
  • Enrolled in the study clinic
  • Willing and able to provide informed consent

You may not qualify if:

  • Patients:
  • Unable or unwilling to provide informed consent
  • Planning to relocate or change service providers/clinics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnyside Office Park

Johannesburg, Gauteng, 2193, South Africa

Location

Related Publications (1)

  • Galaviz KI, Patel SA, Siedner MJ, Goss CW, Gumede SB, Johnson LC, Ordonez CE, Laxy M, Klipstein-Grobusch K, Heine M, Masterson M, Mody A, Venter WDF, Marconi VC, Ali MK, Lalla-Edward ST. Integrating hypertension detection and management in HIV care in South Africa: protocol for a stepped-wedged cluster randomized effectiveness-implementation hybrid trial. Implement Sci Commun. 2024 Oct 14;5(1):115. doi: 10.1186/s43058-024-00640-6.

MeSH Terms

Conditions

Hypertension

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Willem DF Venter, MD, PHD

    Ezintsha, University of the Witwatersrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
There is no masking. This is an intervention study without drugs. Intervention comprises training and education, data and feedback, and task shifting.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Randomized cluster stepped-wedge study design where clinics will be assigned to a time at which they initiate the intervention. There are nine clinics which have been classification (low, medium and high) according to their volume. One clinic from each classification has been randomized to a cluster such that there are three clusters each with a low, medium and high volume clinic.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Director

Study Record Dates

First Submitted

April 12, 2023

First Posted

May 6, 2023

Study Start

June 1, 2023

Primary Completion

May 31, 2025

Study Completion

August 31, 2025

Last Updated

December 10, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations